Literature DB >> 18671940

O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau.

Chun-Hui Yu1, Tong Si, Wei-Hui Wu, Jia Hu, Jin-Tang Du, Yu-Fen Zhao, Yan-Mei Li.   

Abstract

In Alzheimer's disease (AD), tau protein is abnormally hyperphosphorylated and aggregated into paired helical filaments (PHFs). It was discovered recently that tau is also O-GlcNAcylated in human brains. And O-GlcNAcylation may regulate phosphorylation of tau in a site-specific manner. In this work, we focused on the fourth microtubule-binding repeat (R4) of tau, which has an O-GlcNAcylation site-Ser356. The aggregation behavior of this repeat and its O-GlcNAcylated form was investigated by turbidity, precipitation assay and electron microscopy. In addition, conformations of these two peptides were analyzed with circular dichroism (CD). Our results revealed that O-GlcNAcylation at Ser356 could greatly slow down the aggregation speed of R4 peptide. This modulation of O-GlcNAcylation on tau aggregation implies a new perspective of tau pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671940     DOI: 10.1016/j.bbrc.2008.07.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 2.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

Review 3.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

4.  Cell signaling, post-translational protein modifications and NMR spectroscopy.

Authors:  Francois-Xavier Theillet; Caroline Smet-Nocca; Stamatios Liokatis; Rossukon Thongwichian; Jonas Kosten; Mi-Kyung Yoon; Richard W Kriwacki; Isabelle Landrieu; Guy Lippens; Philipp Selenko
Journal:  J Biomol NMR       Date:  2012-09-26       Impact factor: 2.835

Review 5.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

Review 6.  Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease.

Authors:  Satoru Matsuda; Yukie Nakagawa; Ai Tsuji; Yasuko Kitagishi; Atsuko Nakanishi; Toshiyuki Murai
Journal:  Diseases       Date:  2018-04-20

Review 7.  Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.

Authors:  Carolina Alquezar; Shruti Arya; Aimee W Kao
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

8.  Hyperphosphorylation-induced tau oligomers.

Authors:  Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Front Neurol       Date:  2013-08-15       Impact factor: 4.003

9.  Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice.

Authors:  Peter Borghgraef; Clément Menuet; Clara Theunis; Justin V Louis; Herman Devijver; Hervé Maurin; Caroline Smet-Nocca; Guy Lippens; Gerard Hilaire; Harrie Gijsen; Dieder Moechars; Fred Van Leuven
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.